William Patrick Tormey
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Interests
William Patrick Tormey has a total of 80 co-authors. Here are the top co-authors by number of shared publications:
- Tara Moore
Ulster University - Belfast Campus
7 shared publications - Abdullah Al Lawati
Department of Respiratory and Sleep Medicine, Connolly Hospital Dublin, D15 X40D Dublin, Ireland
2 shared publications - Amar Agha
Department of Endocrinology, Beaumont Hospital, Dublin, Ireland
2 shared publications - Aoife Garrahy
Academic Department of Endocrinology, Beaumont Hospital/RCSI Medical School, Dublin, Ireland
2 shared publications - Brendan Byrne
Beaumont Hospital, Dublin, Ireland
2 shared publications - Daniel McCartney
School of Biological Sciences, Dublin Institute of Technology, Dublin 8, Republic of Ireland
2 shared publications
Latest Publications
- Open Access
Hospital Outcomes in Patients Hospitalized for COVID-19 Pneumonia: The Effect of SARS-CoV-2 Vaccination and Vitamin D Status
SARS-CoV-2 vaccination promises to improve outcomes for patients with COVID-19 pneumonia (most notably those with advanced age and at high risk for severe disease). Here, we examine serum 25-Hydroxyvitamin D (25(OH)D) status and outcomes in both old (>70 years) and young vaccinated (n = 80) and unvaccinated (n = 91) subjects, who were hospitalized due to COVID-19 pneumonia in a single center (Connolly Hospital Dublin). Outcomes included ICU admission and mortality. Serum 25(OH)D levels were categorized as D30 (p = 0.036)) and mortality (OR: 24.81 (95% CI: 1.57–392.1) (p = 0.023)) in unvaccinated patients, even after adjustment for major confounders including age, sex, obesity and pre-existing diabetes mellitus. While mortality was consistently higher in all categories of patients over 70 years of age, the highest observed mortality rate of 50%, seen in patients over 70 years with a low vitamin D state (D30), appeared to be almost completely corrected by either vaccination, or having a higher vitamin D state, i.e., mortality was 14% for vaccinated patients over 70 years with D30 and 16% for unvaccinated patients over 70 years with a 25(OH)D level greater than 30 nmol/L. We observe that high mortality from COVID-19 pneumonia occurs in older patients, especially those who are unvaccinated or have a low vitamin D state. Recent vaccination or having a high vitamin D status are both associated with reduced mortality, although these effects do not fully mitigate the mortality risk associated with advanced age.
Open AccessHospital Outcomes in Patients Hospitalized for COVID-19 Pneumonia: The Effect of SARS-CoV-2 Vaccination and Vitamin D Status
SARS-CoV-2 vaccination promises to improve outcomes for patients with COVID-19 pneumonia (most notably those with advanced age and at high risk for severe disease). Here, we examine serum 25-Hydroxyvitamin D (25(OH)D) status and outcomes in both old (>70 years) and young vaccinated (n = 80) and unvaccinated (n = 91) subjects, who were hospitalized due to COVID-19 pneumonia in a single center (Connolly Hospital Dublin). Outcomes included ICU admission and mortality. Serum 25(OH)D levels were categorized as D30 (p = 0.036)) and mortality (OR: 24.81 (95% CI: 1.57–392.1) (p = 0.023)) in unvaccinated patients, even after adjustment for major confounders including age, sex, obesity and pre-existing diabetes mellitus. While mortality was consistently higher in all categories of patients over 70 years of age, the highest observed mortality rate of 50%, seen in patients over 70 years with a low vitamin D state (D30), appeared to be almost completely corrected by either vaccination, or having a higher vitamin D state, i.e., mortality was 14% for vaccinated patients over 70 years with D30 and 16% for unvaccinated patients over 70 years with a 25(OH)D level greater than 30 nmol/L. We observe that high mortality from COVID-19 pneumonia occurs in older patients, especially those who are unvaccinated or have a low vitamin D state. Recent vaccination or having a high vitamin D status are both associated with reduced mortality, although these effects do not fully mitigate the mortality risk associated with advanced age.
- 30 August 2022
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 192 (3) , 1537-1538
Shaun R McCann: Medicine Matters. 40 years working within the Irish healthcare system
- 30 August 2022
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 192 (3) , 1537-1538
Shaun R McCann: Medicine Matters. 40 years working within the Irish healthcare system
- Open Access
Vitamin D Status and Mortality from SARS CoV-2: A Prospective Study of Unvaccinated Caucasian Adults
COVID-19 and a low vitamin D state share common risk factors, which might explain why vitamin D deficiency has been linked with higher COVID-19 mortality. Moreover, measures of serum vitamin D may become lower during systemic inflammatory responses, further confounding the association via reverse causality. In this prospective study (recruited over 12 months), we examined whether the association between a low vitamin D state and in-hospital mortality due to SARS-CoV-2 pneumonia in unvaccinated subjects is explained by (i) the presence of shared risk factors (e.g., obesity, advanced age) or (ii) a reduction in serum 25(OH)D due to COVID-19 (i.e., reverse causality). In this cohort of 232 (mean age = 56 years) patients (all had SARS-CoV-2 diagnosed via PCR AND required supplemental oxygen therapy), we failed to find an association between serum vitamin D and levels of CRP, or other inflammatory markers. However, the hazard ratio for mortality for subjects over 70 years of age (13.2) and for subjects with a serum 25(OH)D level less than 30 nmol·L−1 (4.6) remained significantly elevated even after adjustment for gender, obesity and the presence of diabetes mellitus. Subjects 70 years had significantly higher mortality with a serum 25(OH)D less than 30 nmol·L−1 (11.8% and 55%), than with a serum 25(OH)D greater than 30 nmol·L−1 (2.2% and 25%). Unvaccinated Caucasian adults with a low vitamin D state have higher mortality due to SARS CoV-2 pneumonia, which is not explained by confounders and is not closely linked with elevated serum CRP.
Open AccessVitamin D Status and Mortality from SARS CoV-2: A Prospective Study of Unvaccinated Caucasian Adults
COVID-19 and a low vitamin D state share common risk factors, which might explain why vitamin D deficiency has been linked with higher COVID-19 mortality. Moreover, measures of serum vitamin D may become lower during systemic inflammatory responses, further confounding the association via reverse causality. In this prospective study (recruited over 12 months), we examined whether the association between a low vitamin D state and in-hospital mortality due to SARS-CoV-2 pneumonia in unvaccinated subjects is explained by (i) the presence of shared risk factors (e.g., obesity, advanced age) or (ii) a reduction in serum 25(OH)D due to COVID-19 (i.e., reverse causality). In this cohort of 232 (mean age = 56 years) patients (all had SARS-CoV-2 diagnosed via PCR AND required supplemental oxygen therapy), we failed to find an association between serum vitamin D and levels of CRP, or other inflammatory markers. However, the hazard ratio for mortality for subjects over 70 years of age (13.2) and for subjects with a serum 25(OH)D level less than 30 nmol·L−1 (4.6) remained significantly elevated even after adjustment for gender, obesity and the presence of diabetes mellitus. Subjects 70 years had significantly higher mortality with a serum 25(OH)D less than 30 nmol·L−1 (11.8% and 55%), than with a serum 25(OH)D greater than 30 nmol·L−1 (2.2% and 25%). Unvaccinated Caucasian adults with a low vitamin D state have higher mortality due to SARS CoV-2 pneumonia, which is not explained by confounders and is not closely linked with elevated serum CRP.
- Open Access
- 1 April 2022
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 192 (1) , 169-176
Impact of haemoglobin variants on the use of haemoglobin A1c for the diagnosis and monitoring of diabetes: a contextualised review
HbA1c is the established test for monitoring glycaemic control in diabetes, and intervention trials studying the impact of treatment on glycaemic control and risk of complications focus predominantly on this parameter in terms of evaluating the glycaemic outcomes. It is also the main parameter used when targets for control are being individualised, and more recently, it has been used for the diagnosis of type 2 diabetes. For laboratories performing this test and clinicians utilising it in their decision-making process, a thorough understanding of factors that can impact on the accuracy, and appropriate interpretation of the test is essential. The changing demographic in the Irish population over the last two decades has brought this issue sharply into focus. It is therefore timely to review the utility, performance and interpretation of the HbA1c test to highlight factors impacting on the results, specifically the impact of haemoglobin variants, and the impact of these factors on its utilisation in clinical practice.
- 1 April 2022
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 192 (1) , 169-176
Open AccessImpact of haemoglobin variants on the use of haemoglobin A1c for the diagnosis and monitoring of diabetes: a contextualised review
HbA1c is the established test for monitoring glycaemic control in diabetes, and intervention trials studying the impact of treatment on glycaemic control and risk of complications focus predominantly on this parameter in terms of evaluating the glycaemic outcomes. It is also the main parameter used when targets for control are being individualised, and more recently, it has been used for the diagnosis of type 2 diabetes. For laboratories performing this test and clinicians utilising it in their decision-making process, a thorough understanding of factors that can impact on the accuracy, and appropriate interpretation of the test is essential. The changing demographic in the Irish population over the last two decades has brought this issue sharply into focus. It is therefore timely to review the utility, performance and interpretation of the HbA1c test to highlight factors impacting on the results, specifically the impact of haemoglobin variants, and the impact of these factors on its utilisation in clinical practice.
- Open Access
- 9 March 2021
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 191 (1) , 359-360
Fergus Shanahan: The language of illness
"The language of illness" is a wide ranging exploration of the therapeutic medical process - where it goes right and where is misfires. Communication and empathy are core values explored in the detail exemplifying the art of medicine along side the science. There is a deep seated wisdom and sympathetic philosophy within its pages which is very valuable for the healing and caring professions.
- 9 March 2021
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 191 (1) , 359-360
Open AccessFergus Shanahan: The language of illness
"The language of illness" is a wide ranging exploration of the therapeutic medical process - where it goes right and where is misfires. Communication and empathy are core values explored in the detail exemplifying the art of medicine along side the science. There is a deep seated wisdom and sympathetic philosophy within its pages which is very valuable for the healing and caring professions.
- 15 August 2020
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 190 (2) , 615-623
The diagnostic utility of late night salivary cortisol (LNSF) and cortisone (LNSE) in Cushing’s syndrome
Background Measurement of late night salivary cortisol (LNSF) is useful in the identification of cyclical Cushing’s syndrome (CS); the usefulness of its metabolite cortisone (late night salivary cortisone, LNSE) is less well described. Aim The aim of this study was to determine the utility of measuring LNSE in patients with confirmed CS compared with other diagnostic tests and to analyse serial LNSF measurements for evidence of variable hormonogenesis. Methods This was a retrospective observational study including patients with confirmed CS in whom LNSF and LNSE were measured. Results Twenty-three patients with confirmed CS were included, 21 with Cushing’s disease. LNSF had a sensitivity of 92%, LNSE 87% and combined LNSF/LNSE 94% per sample. Four patients had cyclical hormonogenesis, when the definition of one trough and two peaks was applied to LNSF measurements, and a fifth patient fell just outside the criteria. Six patients had evidence of variable hormonogenesis, defined as doubling of LNSF concentration on serial measurements. Sensitivity of 24-h urinary free cortisol (UFC) was 89% per collection. Sixteen patients had simultaneous measurements of LNSF and UFC; in three patients, they provided discordant results. Conclusion LNSF appears more sensitive than LNSE and UFC in the diagnosis of CS, combining LNSF and LNSE results leads to superior sensitivity. Half of our cohort had evidence of cyclical or variable hormonogenesis. Fluctuations in LNSF did not always correlate with changes in UFC concentration, emphasising the importance of performing more than one screening test, particularly if pretest clinical suspicion is high.
- 15 August 2020
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 190 (2) , 615-623
The diagnostic utility of late night salivary cortisol (LNSF) and cortisone (LNSE) in Cushing’s syndrome
Background Measurement of late night salivary cortisol (LNSF) is useful in the identification of cyclical Cushing’s syndrome (CS); the usefulness of its metabolite cortisone (late night salivary cortisone, LNSE) is less well described. Aim The aim of this study was to determine the utility of measuring LNSE in patients with confirmed CS compared with other diagnostic tests and to analyse serial LNSF measurements for evidence of variable hormonogenesis. Methods This was a retrospective observational study including patients with confirmed CS in whom LNSF and LNSE were measured. Results Twenty-three patients with confirmed CS were included, 21 with Cushing’s disease. LNSF had a sensitivity of 92%, LNSE 87% and combined LNSF/LNSE 94% per sample. Four patients had cyclical hormonogenesis, when the definition of one trough and two peaks was applied to LNSF measurements, and a fifth patient fell just outside the criteria. Six patients had evidence of variable hormonogenesis, defined as doubling of LNSF concentration on serial measurements. Sensitivity of 24-h urinary free cortisol (UFC) was 89% per collection. Sixteen patients had simultaneous measurements of LNSF and UFC; in three patients, they provided discordant results. Conclusion LNSF appears more sensitive than LNSE and UFC in the diagnosis of CS, combining LNSF and LNSE results leads to superior sensitivity. Half of our cohort had evidence of cyclical or variable hormonogenesis. Fluctuations in LNSF did not always correlate with changes in UFC concentration, emphasising the importance of performing more than one screening test, particularly if pretest clinical suspicion is high.
- 9 December 2019
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 189 (1) , 1-2
Hyponatraemia, harm reduction and the O’Hara report from Northern Ireland
- 9 December 2019
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 189 (1) , 1-2
Hyponatraemia, harm reduction and the O’Hara report from Northern Ireland
- 2 October 2018
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 188 (3) , 959-961
Critical biochemistry values and patient safety in primary care
- 2 October 2018
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 188 (3) , 959-961
Critical biochemistry values and patient safety in primary care
- 1 August 2018
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 187 (3) , 543-544
In recognition of Ireland's doctor scientists: Carel le Roux, Seamas Donnelly and Michael P Keane
- 1 August 2018
- Published by Springer Nature in Irish Journal of Medical Science (1971 -)
- Vol. 187 (3) , 543-544
In recognition of Ireland's doctor scientists: Carel le Roux, Seamas Donnelly and Michael P Keane